Swiss pharmaceutical firm Actelion Ltd (ALIOF.PK) has appointed André Muller as its Chief Financial Officer and member of its Executive Committee, replacing Andrew Oakley, who would focus on opportunities outside the company. Mr. Muller will take office on01 September 2013.
Commenting on André Muller, Jean-Paul Clozel, M.D. and Chief Executive of Actelion, said: "He brings vast experience as a pharmaceutical finance executive and I am confident that André will make a significant contribution to Actelion's continued success."
André C. Muller is a French citizen joining Actelion from Pierre Fabre SA, an international pharmaceutical and cosmetic group, where he held several roles from 1994 until 2011, most recently as Chief Financial Officer.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org